UCCB01-147 [also known as Tat-NPEG4(IETDV)(2), (Tat-N-dimer)], a dimeric PSD-95 inhibitor, was observed to be neuroprotective in an experimental stroke model [65] but failed to demonstrate those beneficial effects in experimental TBI [66]. The gene discussed is TAT; the disease is stroke disorder.